Literature DB >> 2136803

Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16).

T W Huizinga1, M Kleijer, P A Tetteroo, D Roos, A E von dem Borne.   

Abstract

Neutrophils express two distinct types of receptor for the Fc region of IgG, FcRII and FcRIII, in amounts of 10,000 to 20,000 FcRII (40 Kd) and 100,000 to 200,000 FcRIII (50 to 80 Kd) per neutrophil. We showed that the FcRIII exhibits genetically determined heterogeneity, detectable by differences in electrophoretic mobility with sodium dodecyl sulfate (SDS) as well as by reaction with antibodies against the biallelic neutrophil-specific antigen system NA. FcRIII was precipitated with an FcRIII-specific monoclonal antibody (MoAb) from the neutrophils of 35 donors. NA1NA1 donors expressed an FcRIII with a molecular weight (mol wt) of 50 to 65 Kd, NA1NA2 donors expressed an FcRIII with a mol wt of 50 to 80 Kd, and NA2NA2 donors expressed an FcRIII with a mol wt of 65 to 80 Kd. Statistical analysis showed that the electrophoretic heterogeneity corresponds with the NA polymorphism (k = 1). Sequential immunoprecipitation with a MoAb against NA1 and a MoAb against anti-FcRIII, followed by SDS-polyacrylamide gel electrophoresis (PAGE), showed that NA1-FcRIII is distinct from NA2-FcRIII. Moreover, immunoprecipitation with a MoAb against NA1 yielded a protein of 50 to 65 Kd, and immunoprecipitation with human anti-NA2 sera or an MoAb against NA2 yielded a protein of 65 to 80 Kd. Preincubation of NA1NA2 neutrophils with F(ab')2 fragments of an MoAb against anti-NA1 reduced binding of IgG dimers to these cells with about 50%, whereas it completely prevented binding of the dimers to NA1NA1 neutrophils. Inhibition experiments with the MoAb against NA2 yielded the same results for NA1NA2 cells, whereas binding of IgG dimers to NA2NA2 cells was completely prevented. Thus, the products of both NA alleles bind IgG. Immunoprecipitation from the medium of neutrophils either stimulated with formyl- methionyl-leucyl-phenylalanine (FMLP) or treated with glycosyl-phosphatidyl-inositol-specific phospholipase C (GPI- PLC) showed that both the NA1-FcRIII and the NA2-FcRIII are released from the cell surface, indicating that both forms of FcRIII have some structural features in common. Deglycosylation of FcRIII from homozygous donors yielded material that showed several bands on SDS-PAGE. GPI-PLC treatment of neutrophils indicated that all of this material is phosphatidyl-inositol linked.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136803

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

Review 1.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease.

Authors:  Shoichiro Taniuchi; Midori Masuda; Masayuki Teraguchi; Yumiko Ikemoto; Yutaka Komiyama; Hakuo Takahashi; Minoru Kino; Yohnosuke Kobayashi
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

Review 5.  Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions.

Authors:  David F Stroncek; Emmanuel Fadeyi; Sharon Adams
Journal:  Transfus Med Rev       Date:  2007-10

6.  Autoimmune neutropenia of infancy.

Authors:  E G Lyall; G F Lucas; O B Eden
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

7.  Evidence for non-random distribution of Fcgamma receptor genotype combinations.

Authors:  W-Ludo van der Pol; Marc D Jansen; Wim J Sluiter; Bart van de Sluis; Fredriek G J Leppers-van de Straat; Tetsuo Kobayashi; Rudi G J Westendorp; Tom W J Huizinga; Jan G J van de Winkel
Journal:  Immunogenetics       Date:  2003-06-26       Impact factor: 2.846

8.  Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.

Authors:  Takayuki Ota; Miyo Aoki-Ota; Bao Hoa Duong; David Nemazee
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  Iso-immune neonatal neutropenia due to an anti-Fc receptor III (CD16) antibody.

Authors:  J Cartron; J L Celton; P Gane; A Astier; W H Fridman; G Boissinot; J P Cartron
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

10.  Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia.

Authors:  Marcin Wojciech Wlodarski; Zachary Nearman; Ying Jiang; Alan Lichtin; Jaroslaw Pawel Maciejewski
Journal:  Exp Hematol       Date:  2008-03       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.